Safety of Combining Lyrica (Pregabalin) and Melatonin
Taking melatonin together with Lyrica (pregabalin) is generally safe, with no documented pharmacokinetic interactions or contraindications, though patients should be monitored for additive sedation.
Pharmacological Compatibility
The FDA labeling for Lyrica explicitly states that pregabalin "is predominantly excreted unchanged in the urine, undergoes negligible metabolism in humans (<2% of a dose recovered in urine as metabolites), and does not bind to plasma proteins" 1. This pharmacokinetic profile means pregabalin is unlikely to interact with other medications through metabolic pathways or protein binding displacement 1.
Importantly, the FDA label notes that while pregabalin shows "additive effects on cognitive and gross motor functioning" when combined with CNS depressants like oxycodone, lorazepam, or ethanol, no clinically important effects on respiration were observed 1. Melatonin is not listed among medications with documented interactions.
Clinical Evidence Supporting Co-Administration
Multiple research studies have actually examined the combined use of pregabalin and melatonin, demonstrating safety and potential synergistic benefits:
A randomized trial in painful diabetic neuropathy found that melatonin (6 mg/day) as adjunct to pregabalin (150 mg/day) was well-tolerated with no reported safety concerns over 8 weeks 2
A perioperative study comparing melatonin 6 mg versus pregabalin 150 mg found both agents safe when used separately, with comparable sedation levels 3
Animal studies examining combined melatonin and pregabalin administration showed melatonin actually protected against pregabalin-induced toxicity through antioxidant mechanisms 4, 5
Practical Considerations
What to Monitor:
- Sedation/drowsiness: Both agents can cause mild sedation, so additive effects are theoretically possible though not clinically documented
- Dizziness: Pregabalin commonly causes dizziness; melatonin may contribute minimally
- Cognitive effects: Monitor for confusion or impaired concentration, particularly in elderly patients
Dosing Context:
The evidence base uses melatonin doses of 3-15 mg with pregabalin doses of 150-300 mg daily without safety signals 2, 6. Standard over-the-counter melatonin doses (1-10 mg) fall well within this range.
Important Caveats
General CNS depressant precautions apply: The 2008 AASM insomnia guidelines note that all sedative/hypnotics have "additive effect on psychomotor performance with concomitant CNS depressants" 7. While this warning applies broadly to sedating medications, it does not constitute a specific contraindication for the melatonin-pregabalin combination.
Elderly patients warrant extra caution: Both medications require dose adjustments in older adults. Pregabalin requires renal dose adjustment 1, and melatonin's effects may be more pronounced in this population.
Avoid alcohol: The FDA label specifically warns against combining pregabalin with alcohol and other sedatives 7, 1.
Bottom Line
The combination is pharmacologically compatible with no documented drug-drug interactions. Clinical research has safely combined these agents, and animal studies suggest melatonin may even provide protective effects. Monitor for additive sedation, particularly when initiating therapy or in vulnerable populations (elderly, renal impairment), but there is no contraindication to concurrent use.